is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The Halcyon system is Varian's newest cancer treatment device, engineered to simplify and enhance virtually every aspect of image-guided volumetric intensity-moduled radiotherapy (IMRT).
Varian’s Vision of a World Without Fear of Cancer
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the fear of cancer? What might that world look like? Is it even possible or just a science fiction dream? Varian (NYSE: VAR) does not believe it is science fiction and has published a new vision paper, "The Future of Cancer Care: Moving from Promise to Reality," to describe this future state and detail the challenges that must be overcome to realize it.
Go here to learn more, click here.